Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
The study demonstrated that the <i>392A</i> > <i>G</i> polymorphism of the <i>CYP3A4</i>*<i>1B</i> gene <i>(rs2740574)</i> in patients with acute alcoholic hallucinosis does not affect the efficacy and safety rates of haloperidol therapy.
Authors
- I A Zaytsev
- К. А. Акмалова (ORCID: https://orcid.org/0000-0003-3505-8520)
- А. Е. Петухов (ORCID: https://orcid.org/0000-0002-4855-4235)
- П. О. Бочков (ORCID: https://orcid.org/0000-0001-8555-5969)
- Evgeny Bryun (ORCID: https://orcid.org/0000-0002-9329-1155)
- Aleksandra Aleksandrovna Parkhomenko (ORCID: https://orcid.org/0000-0001-8008-6884)
- Irina V. Bure (ORCID: https://orcid.org/0000-0003-2043-5848)
- V A Ivanchenko
- S A Pozdniakov
- Valentin Yurievich Skryabin (ORCID: https://orcid.org/0000-0002-4942-8556)
- Dmitry Alekseevich Sychev (ORCID: https://orcid.org/0000-0002-4496-3680)
- Михаил Сергеевич Застрожин (ORCID: https://orcid.org/0000-0002-3964-9726)
- Smirnov Vv (ORCID: https://orcid.org/0000-0002-8232-6682)
Institutions
- California Department of Toxic Substances Control (US)
- American Society of Addiction Medicine (US)
- Moscow Clinical Scientific Center (RU)
- Russian Medical Academy of Continuous Professional Education (RU)
- National Drug Addiction Center (BG)
- Institute of Plant Genetics, Polish Academy of Sciences (PL)
- Research Center of Neurology (RU)
- Institute of Predictive and Personalized Medicine of Cancer (ES)
- Federal Medical-Biological Agency (RU)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-08-12
- DOI
- https://doi.org/10.64719/pb.4471
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00